
Newron Pharmaceuticals SpA
SIX:NWRN

Newron Pharmaceuticals SpA?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
6.03
10.72
|
Price Target |
|
We'll email you a reminder when the closing price reaches CHF.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does Newron Pharmaceuticals SpA hold over its rivals?
What risks and challenges
does Newron Pharmaceuticals SpA face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Newron Pharmaceuticals SpA.
Provide an overview of the primary business activities
of Newron Pharmaceuticals SpA.
What unique competitive advantages
does Newron Pharmaceuticals SpA hold over its rivals?
What risks and challenges
does Newron Pharmaceuticals SpA face in the near future?
Has there been any significant insider trading activity
in Newron Pharmaceuticals SpA recently?
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Newron Pharmaceuticals SpA.
Provide P/S
for Newron Pharmaceuticals SpA.
Provide P/E
for Newron Pharmaceuticals SpA.
Provide P/OCF
for Newron Pharmaceuticals SpA.
Provide P/FCFE
for Newron Pharmaceuticals SpA.
Provide P/B
for Newron Pharmaceuticals SpA.
Provide EV/S
for Newron Pharmaceuticals SpA.
Provide EV/GP
for Newron Pharmaceuticals SpA.
Provide EV/EBITDA
for Newron Pharmaceuticals SpA.
Provide EV/EBIT
for Newron Pharmaceuticals SpA.
Provide EV/OCF
for Newron Pharmaceuticals SpA.
Provide EV/FCFF
for Newron Pharmaceuticals SpA.
Provide EV/IC
for Newron Pharmaceuticals SpA.
Show me price targets
for Newron Pharmaceuticals SpA made by professional analysts.
What are the Revenue projections
for Newron Pharmaceuticals SpA?
How accurate were the past Revenue estimates
for Newron Pharmaceuticals SpA?
What are the Net Income projections
for Newron Pharmaceuticals SpA?
How accurate were the past Net Income estimates
for Newron Pharmaceuticals SpA?
What are the EPS projections
for Newron Pharmaceuticals SpA?
How accurate were the past EPS estimates
for Newron Pharmaceuticals SpA?
What are the EBIT projections
for Newron Pharmaceuticals SpA?
How accurate were the past EBIT estimates
for Newron Pharmaceuticals SpA?
Compare the revenue forecasts
for Newron Pharmaceuticals SpA with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Newron Pharmaceuticals SpA and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Newron Pharmaceuticals SpA against its competitors.
Analyze the profit margins
(gross, operating, and net) of Newron Pharmaceuticals SpA compared to its peers.
Compare the P/E ratios
of Newron Pharmaceuticals SpA against its peers.
Discuss the investment returns and shareholder value creation
comparing Newron Pharmaceuticals SpA with its peers.
Analyze the financial leverage
of Newron Pharmaceuticals SpA compared to its main competitors.
Show all profitability ratios
for Newron Pharmaceuticals SpA.
Provide ROE
for Newron Pharmaceuticals SpA.
Provide ROA
for Newron Pharmaceuticals SpA.
Provide ROIC
for Newron Pharmaceuticals SpA.
Provide ROCE
for Newron Pharmaceuticals SpA.
Provide Gross Margin
for Newron Pharmaceuticals SpA.
Provide Operating Margin
for Newron Pharmaceuticals SpA.
Provide Net Margin
for Newron Pharmaceuticals SpA.
Provide FCF Margin
for Newron Pharmaceuticals SpA.
Show all solvency ratios
for Newron Pharmaceuticals SpA.
Provide D/E Ratio
for Newron Pharmaceuticals SpA.
Provide D/A Ratio
for Newron Pharmaceuticals SpA.
Provide Interest Coverage Ratio
for Newron Pharmaceuticals SpA.
Provide Altman Z-Score Ratio
for Newron Pharmaceuticals SpA.
Provide Quick Ratio
for Newron Pharmaceuticals SpA.
Provide Current Ratio
for Newron Pharmaceuticals SpA.
Provide Cash Ratio
for Newron Pharmaceuticals SpA.
What is the historical Revenue growth
over the last 5 years for Newron Pharmaceuticals SpA?
What is the historical Net Income growth
over the last 5 years for Newron Pharmaceuticals SpA?
What is the current Free Cash Flow
of Newron Pharmaceuticals SpA?
Discuss the annual earnings per share (EPS)
trend over the past five years for Newron Pharmaceuticals SpA.
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
Market Cap | EV/EBITDA | ||||
---|---|---|---|---|---|
IT |
![]() |
Newron Pharmaceuticals SpA
SIX:NWRN
|
139.5m CHF | 6.7 | |
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
756B USD | 36.5 |
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP | 3 846.3 |
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
406.8B USD | 13.7 |
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
2T DKK | 13 |
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
207.8B CHF | 9.4 |
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
179.9B CHF | 10 |
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
165.5B GBP | 131 |
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
210.7B USD | 9 |
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
183.8B USD | 292.4 |
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
144.2B USD | 7.8 |
|
EBITDA Growth | EV/EBITDA to Growth | |||||
---|---|---|---|---|---|---|
IT |
![]() |
Newron Pharmaceuticals SpA
SIX:NWRN
|
Average EV/EBITDA:
397.8
6.7
|
N/A | N/A | |
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
36.5
|
30%
|
1.2 |
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
3 846.3
|
36%
|
106.8 |
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
13.7
|
7%
|
2 |
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
13
|
13%
|
1 |
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
9.4
|
5%
|
1.9 |
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
10
|
5%
|
2 |
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
131
|
10%
|
13.1 |
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
9
|
8%
|
1.1 |
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
292.4
|
N/A | N/A |
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
7.8
|
2%
|
3.9 |
|
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.